Renal Impairment Study With ASP1941

Clinical trial NCT01302028 · COMPLETED

Trial details

NCT number: NCT01302028
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2010-01-22
Primary completion: 2010-06-26
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.